{"id":"NCT00939900","sponsor":"Seoul National University Bundang Hospital","briefTitle":"Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head","officialTitle":"Multicenter, Open-labeled, Randomized Clinical Trial to Determine the Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2012-06","completion":"2012-06","firstPosted":"2009-07-15","resultsPosted":"2015-07-02","lastUpdate":"2015-07-02"},"enrollment":110,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Avascular Necrosis of Femoral Head"],"interventions":[{"type":"DRUG","name":"zoledronic acid (aclasta)","otherNames":["aclasta"]}],"arms":[{"label":"aclasta","type":"EXPERIMENTAL"},{"label":"control","type":"NO_INTERVENTION"}],"summary":"The purpose of this study is to test the effect of zoledronic acid over 2 years in preventing early collapse and progression of joint dome depression (â‰¥ 2 mm by X-ray) of the femoral head in patients with large (\\> 30%: criteria according to Kim et al) nontraumatic osteonecrosis.","primaryOutcome":{"measure":"Number of Participants With Femoral Head Collapse Within 24 Months","timeFrame":"Measurements were done at 6, 12, 24 months","effectByArm":[{"arm":"Aclasta","deltaMin":29,"sd":null},{"arm":"Control","deltaMin":22,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":7},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":55},"commonTop":[]}}